Abstract:Using the existing collected data from European and African countries, we present a statistical analysis of forecast of the future number of daily deaths and infections up to 10 September 2020. We presented numerous statistical analyses of collected data from both continents using numerous existing statistical theories. Our predictions show the possibility of the second wave of spread in Europe in the worse scenario and an exponential growth in the number of infections in Africa. The projection of statistical … Show more
“…The number of cases in the 2nd wave was much greater than the 1st wave ( Fig. 1 C) which was predicted earlier by Atangana et al [15] . Cases per month were highest in the Americas but the highest deaths were observed in Europe region although, infection rate and fatality are coming down gradually.…”
Section: Current Covid-19 Epidemic Statussupporting
Novel coronavirus 2019 (COVID-19) is a zoonosis that revised the global economic and societal progress since early 2020. The SARS-CoV-2 has been recognized as the responsible pathogen for COVID-19 with high infection and mortality rate potential. It has spread in 192 countries and infected about 1.5% of the world population, and still, a proper therapeutic approach is not unveiled. COVID-19 indication starts with fever to shortness of breathing, leading to ICU admission with the ventilation support in severe conditions. Besides the symptomatic mainstay clinical therapeutic approach, only Remdesivir has been approved by the FDA. Several pharmaceutical companies claimed different vaccines with exceptionally high efficacy (90–95%) against COVID-19; how long these vaccines can protect and long-term safety with the new variants are unpredictable. After the worldwide spread of the COVID-19 pandemic, numerous clinical trials with different phases are being performed to find the most appropriate solution to this condition. Some of these trials with old FDA-approved drugs showed promising results. In this review, we have precisely compiled the efforts to curb the disease and discussed the clinical findings of Ivermectin, Doxycycline, Vitamin-D, Vitamin-C, Zinc, and cannabidiol and their combinations. Additionally, the correlation of these molecules on the prophylactic and diseased ministration against COVID-19 has been explored.
“…The number of cases in the 2nd wave was much greater than the 1st wave ( Fig. 1 C) which was predicted earlier by Atangana et al [15] . Cases per month were highest in the Americas but the highest deaths were observed in Europe region although, infection rate and fatality are coming down gradually.…”
Section: Current Covid-19 Epidemic Statussupporting
Novel coronavirus 2019 (COVID-19) is a zoonosis that revised the global economic and societal progress since early 2020. The SARS-CoV-2 has been recognized as the responsible pathogen for COVID-19 with high infection and mortality rate potential. It has spread in 192 countries and infected about 1.5% of the world population, and still, a proper therapeutic approach is not unveiled. COVID-19 indication starts with fever to shortness of breathing, leading to ICU admission with the ventilation support in severe conditions. Besides the symptomatic mainstay clinical therapeutic approach, only Remdesivir has been approved by the FDA. Several pharmaceutical companies claimed different vaccines with exceptionally high efficacy (90–95%) against COVID-19; how long these vaccines can protect and long-term safety with the new variants are unpredictable. After the worldwide spread of the COVID-19 pandemic, numerous clinical trials with different phases are being performed to find the most appropriate solution to this condition. Some of these trials with old FDA-approved drugs showed promising results. In this review, we have precisely compiled the efforts to curb the disease and discussed the clinical findings of Ivermectin, Doxycycline, Vitamin-D, Vitamin-C, Zinc, and cannabidiol and their combinations. Additionally, the correlation of these molecules on the prophylactic and diseased ministration against COVID-19 has been explored.
“…A fractional-order COVID-19 model with delay has been proposed in [ 19 ]. Atangana et al in [ 20 ] have discussed a mathematical model of COVID-19 with deterministic and stochastic approaches. The authors in [ 21 – 23 ] have also simulated the dynamics of 2019-nCOV by using effective mathematical models.…”
In this study, our aim is to explore the dynamics of COVID-19 or 2019-nCOV in Argentina considering the parameter values based on the real data of this virus from March 03, 2020 to March 29, 2021 which is a data range of more than one complete year. We propose a Atangana–Baleanu type fractional-order model and simulate it by using predictor–corrector (P-C) method. First we introduce the biological nature of this virus in theoretical way and then formulate a mathematical model to define its dynamics. We use a well-known effective optimization scheme based on the renowned trust-region-reflective (TRR) method to perform the model calibration. We have plotted the real cases of COVID-19 and compared our integer-order model with the simulated data along with the calculation of basic reproductive number. Concerning fractional-order simulations, first we prove the existence and uniqueness of solution and then write the solution along with the stability of the given P-C method. A number of graphs at various fractional-order values are simulated to predict the future dynamics of the virus in Argentina which is the main contribution of this paper.
“…Consequently, the discrete SEIR model can be an excellent motivation to work with students and better process all the information that comes to us on these topics. In what follows, to refer to the original model of differential equations, we will use the expression ’continuous model’ and for more details see [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] .…”
To describe the main propagation of the COVID-19 and has to find the control for the rapid spread of this viral disease in real life, in current manuscript a discrete form of the SEIR model is discussed. The main aim of this is to describe the viral disease in simplest way and the basic properties that are related with the nature of curves for susceptible and infected individuals are discussed here. The elementary numerical examples are given by using the real data of India and Algeria.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.